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ANALYSIS OF THE PREVALENCE OF MORTALITY 
FROM TUBERCULOSIS IN DIVERSE REGIONS OF 
BRAZIL ACCORDING TO DATASUS 
ANÁLISE SOBRE A PREVALÊNCIA DE MORTALIDADE POR 
TUBERCULOSE NAS DIVERSAS REGIÕES DO BRASIL DE 
ACORDO COM DATASUS 
 
Talita Costa Barbosa¹*; Lindemberg Barbosa Júnior²; Larissa Toloy Bigaran¹; 







ABSTRACT: Tuberculosis is a bacterial disease caused by Mycobacterium tuberculosis. This can 
affect the lung, as well as other organs in the human body. It is a neglected disease in Brazil, and has 
a high mortality rate. The objective is to understand the prevalence rate of deaths in the different 
regions of Brazil according to DATASUS, from 2014 to 2018. The materials and methods were 
research of articles in available databases, in addition to the collection of secondary data available on 
the DATASUS platform. As a result of the research, the highest rates were in the Southeast, followed 
by the Northeast. It is concluded from the results that this fact may be related to pre-existing risk 
factors and prevention factors. From this, it will be possible to analyze it to propose actions to mitigate 
this statistic. 
KEYWORDS: tuberculosis, mortality, epidemiology 
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Tuberculosis is defined as a bacterial disease, caused 
by a bacterium, Mycobacterium tuberculosis, also 
called Koch's bacillus. It affects the lung, but can reach 
other organs of the human body, depending on its 
severity. Many people can serve as incubators for 
Koch's bacillus, even if they don't have the symptoms 
caused by tuberculosis. Approximately 70,000 
Brazilians are diagnosed with tuberculosis each year 
(RABAHI et al., 2017). 
Tuberculosis is a major public health problem and is 
considered one of the neglected diseases in Brazil. It 
is one of the causes of death among communicable 
diseases in adults (CECCON et al., 2017). 
Its high prevalence associated with the great potential 
for dissemination has made it classified as an 
emerging condition, which has high and increasing 
levels of morbidity and mortality, especially in poor 
countries. According to the high rates presented in the 
studies, it is concluded that among the reasons for the 
situation, the relationship between tuberculosis and 
poverty and social exclusion stands out, these issues 
being central to vulnerability to illness (SILVA, MELLO, 
MIGLIORI, 2020). 
Risk factors for tuberculosis are diabetes, smoking, 
alcohol and use of other drugs (BOFFO, et al., 2017). 
And the aim of this study was to analyze the 
prevalence of deaths from respiratory tuberculosis in 







The study was a documentary research. Statistical 
data were used, from the database of the Department 
of Informatics of the Unified Health System 
(DATASUS), from 2014 to 2018, using the respiratory 
tuberculosis filters in the North, Northeast, South, 





 The regions with the highest incidence were the 
Southeast, followed by the Northeast, within the period 
from 2014 to 2018. The total number of cases was 
20,664. Thus, the percentage of deaths representative 
of the Southeast region was 42.96% of the total deaths 
over the entire period. In the Northeast it was 32.72%. 
The remainder, corresponding to 24.36%, represents 
the North, South, and Northeast regions. which can be 
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Figure 1 - Identification of the percentage of mortality 
from tuberculosis according to the regions of Brazil 
from 2014 to 2018 
	





Thus, according to the results presented, it is 
concluded that the highest incidence of cases is in the 
Southeast, followed by the Northeast. This fact may be 
closely related to risk factors and forms of prevention. 
Thus, it is important to carry out health education so 
that it can provide guidance on tuberculosis, in addition 
to the elaboration of public policies to improve the 
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DIABETIS AND ITS BIGGEST SUSCEPTIBILITY TO THE SERIOUS 
FORMS OF COVID-19 
DIABETES E SUA MAIOR SUSCETIBILIDADE AS FORMAS GRAVES DA COVID-
19 
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ABSTRACT: According to Sociedade Brasileira de Diabetes (2020) the biggest risk of evolution of the 
serious forms of COVID-19 is related with a long history in high rates of glucose, bad metabolic 
control, presence of micro or macro vasculars complications, concurrent diseases and specially in 
seniors older than 60. The objective of this work is to identify the evidence available in the literature 
on the relationship between the SARS-CoV-2 pandemic with diabetes and whether both increase the 
severity of COVID-19. It’s a narrative review of the literature, in which it was selected articles 
published since March 2020 on the search basis of PubMed, Scielo and LILACS. Although the 
pathophysiology of COVID-19 is not completely clear, studies have demonstrated a relationship 
between diabetes and the mortality rate of COVID-19. It is identified that when related to diabetes 
mellitus the cases of COVID-19 have a bigger susceptibility to the gravest forms, raising the numbers 
of hospitalizations and death rate. 
KEY-WORDS: Pandemic; Diabetes; COVID-19 
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The pandemic of this century emerged on December 
31, 2019 when the World Health Organization (WHO) 
received notification of cases of unexplained 
pneumonia in the city of Wuhan, China, with the 
probable etiology of the new Corona virus strain. A few 
days later, the suspicion was confirmed and, even 
during this period, the WHO declared a public health 
emergency of an international character, since the 
speed of spread of the disease was becoming a 
concern. However, it was only on March 11 that this 
disease started to be classified as a pandemic (World 
Health Organization, 2020). 
COVID-19 it’s the name of the disease caused by the 
new coronavirus, SARS-CoV-2. Although it is a 
pathology still unknown, WHO defined some groups of 
risk according to the gravity of the disease, including 
carriers of lung diseases, hypertension, senior citizens, 
cardiopathy patients, cancer patients, diabetics, 
among others carriers of pre-existing comorbities. In 
the context of diabetes, according to Sociedade 
Brasileira de Diabetes (2020), the biggest risk of 
evolution of the serious forms of COVID-19 is related 
with a long history in high rates of glucose, bad 
metabolic control, presence of micro or macro 
vasculars complications, concurrent diseases and 
specially in seniors older than 60. A Chinese study 
with 1099 patients with COVID-19 showed that in 173 
carriers of the serious forms of the disease, 16,2% 
were patients with diabetes mellitus (GUAN et al., 
2020). 
Given the above, the objective of this work is to identify 
the evidence available in the literature on the 
relationship between the SARS-CoV-2 pandemic with 
diabetes and whether both increase the severity of 
COVID-19 and, consequently, lead to a greater 
number deaths of those infected. 
 
 
2 . METHODOLOGY 
 
It’s a narrative review of the literature, in which it was 
selected articles published since March 2020 on the 
search basis of PubMed, Scielo and LILACS. It was 
used the terms “diabetes mellitus”, “coronavirus” and 
“mortality’’.The Boolean operator employed was AND 
and as a filter the publications of the last year. In 
PubMed, 7 articles were found, of which 4 were 
selected and read in full. In Scielo, 4 articles were 
found, with a duplication of 3 of them, thus selecting 1 
of them for reading. In LILACS, 6 articles were found, 
4 of which were most relevant to the topic of this 
review. 
 
3 . RESULTS AND DISCUSSION 
 
 Although it isn’t completely clear the fisiopatology of 
COVID-19, a study showed a significative relation 
between diabetes and the mortality rate from COVID-
19 through a chance of 1,9 (KUMAR el al., 2020). 
Another study showed that the growing chances of 
death at hospitals are associated with advanced age 
and organic failures and dimer-d higher than 1 μg / mL 
in admission. (ZHOU, 2020). 
The authors cited and some more have established 
studies to demonstrate this important relationship. 
These studies and their respective conclusions are 
presented in table 1. 
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Table 1 - Authors who studied the relationship 
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Although there are gaps on the relation of the infection 
by SARS-CoV-2, it is identified that when related to 
diabetes mellitus the cases have a bigger susceptibility 
to the gravest forms, raising the numbers of 
hospitalizations and death rate. Also, monitoring the 
glucose and adjusting medications in general, because 
they are effective not just to the prevention of 
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ABSTRACT: Introduction: About 1 billion people live in informal settlements worldwide. Poor access 
to infrastructure affects health, leading to an increase in the spread of diseases, including the new 
coronavirus. Aiming to contribute to the safety and quality of human settlements, this study suggests a 
method to measure poorly infrastructured living spaces' susceptibility to the spread of diseases. 
Methods: The methodology adapts the Environmental Health Index in Slums (ISA/F), published by 
Almeida in 1999 and adds indicators related to urban quality, that can influence the spread of 
diseases. Results and Discussion: The preliminary results are the indicators, which were evaluated 
and qualified according to their influence on the general index. Conclusion: The index can be applied 
in local slums to test the indicators and undergo comparative studies. The development of the index is 
an important method to help to comprehend how physical, social and economic factors favor the 
spread of diseases in slums and can be an important tool for authorities to define priorities to improve 
public health. 
Keywords:  Vulnerability; Environmental Health; Public Health; Global Health.		
1. Students of the medicine course. Centro Universitário de Belo Horizonte. Belo Horizonte, Minas Gerais. E-mail: 
vgvirginiagomes@gmail.com 
2.  Professor of Architecture and Urbanism. UNICURITIBA, Curitiba, Paraná. E-mail: 
debora.furlan@prof.unisociesc.com.br 




                          ISSN: 1984-7688 
	
	 e-Scientia, Belo Horizonte, v. 14, n. 1  (2021).  






According to the United Nations Indicators (2019), 
about 1 billion people worldwide live in slums and 
other types of informal settlements. This number 
corresponds to an increase of 23.5% when compared 
to 2018 and indicates an accelerated rate of growth in 
poverty worldwide. Thereby, the lack of access to 
inappropriate urban amenities and services have 
become more common, negatively affecting the health 
and safety of these people, besides intensifying 
inequality and decreasing livelihood conditions.  
In the beginning of 2020 the world faced a new 
alarming emergency, the COVID-19 pandemic, which 
has encouraged scientists to study the prevention and 
cure of many pathologies. The pandemic has 
emphatically underlined the vulnerability of slums to 
the spread of diseases. According to Instituto Igarapé, 
“slums are becoming a focal point of the pandemic” as 
areas “disproportionately impacted” with COVID 
outbreaks (CityMetric, 2020). Like so, the World Bank 
has stressed that the health and economic impact of 
the pandemic are “far more devastating for slum 
dwellers” (World Bank, 2020). 
While the increase in the number of studies addressing 
this problem is important, to the best of our knowledge, 
there has been no published attempt to develop an 
index to measure the slum’s susceptibility to the 
spread of diseases, such as the new coronavirus, 
which can spread more easily where prevention 
conditions are precarious. Therefore, this study aims to 
develop an index to measure the relationship between 
precariousness and the spread of diseases, to 
contribute to this discussion by documenting and 
evaluating urban health related indicators  
This paper presents a summary of the objectives and 
structure of an ongoing study, which integrates a 
multidisciplinary undergraduate research project 
developed by the brazilian Ânima Educação group, 
involving researchers from the Architecture and 
Urbanism, Biomedicine, Civil Engineering and 
Medicine departments of UNICURITIBA in Curitiba/PR 






To understand and select the indicators which 
contribute to the vulnerability Index,  a literature review 
and documental study were developed. The choice of 
indicators was based on its suitability to measure the 
relationship between the items that condition informal 
urban settlements to precariousness, and the spread 
of diseases. To select the themes of the indicators, 
important bibliographic references in studies on 
favelas were consulted, as well as current publications 
by local research groups that analyze Covid-19 and its 
effects on favelas, such as the group “Paraná against 
Covid”. 
The methodology used to develop the Index is based 
on the Environmental Health Indicator in Slums (ISA/F) 
developed by Almeida (1999). The study adds new 
indicators to those used by the autor, resulting from 
the applied research that was previously developed.  
The new indicators were developed using data 
collected by the Latin American NGO TETO, a 
community organization that works with informal 
settlements, and complemented by information 
 
                          ISSN: 1984-7688 
	
	 e-Scientia, Belo Horizonte, v. 14, n. 1  (2021).  




reported through public agencies, such as the civil 
defense and Brazil’s Unified Health System (SUS).  
 
 
3. RESULTS AND DISCUSSION 
 
The preliminary results of this ongoing study are the 
indicators which were organized by category and 
score, using the method proposed by Almeida (1999) 
in the ISA/F.  
The indicators of the environmental health index in 
favelas by almeida are these: Water Supply Coverage 
Indicator, Coverage in Sewage Collection and Septic 
Tanks Indicator, Garbage Collection Indicator, 
Drainage Indicator, Circulation Path Indicator, 
Geological Geotechnical Safety Indicator, Gross 
Demographic Density Indicator, Electricity Indicator, 
Land Regularization Indicator, Street Maintenance 
Indicator, Public Lighting Indicator, Public Space 
Indicator, Income Indicator and Education Indicator. As 
an example, the Water Supply Coverage Indicator 
measures the access of the houses to the public water 
system. It was maintained as an indicator, since it 
serves several purposes, such as personal 
consumption, bathing, washing food, watering crops, 
and therefore it directly interferes in the spread of 
mainly parasites and other pathologies which can be 
transmitted by water. Also, the lack of access to safe 
water sources  can complicate the prevention of the 
spread of the new coronavirus. 
The indicators added to those already selected by 
Almeida (1999) are these: Rustic households, 
Households without an exclusive sanitary unit, 
Excessive rental spending, Excessive density or 
cohabitation, Work formality, Longevity, Concentration 
of elderly people, Existence of air pollution emitters, 
Flood risk and Paving type. The density or cohabitation 
indicator was included, for example, in reference to the 
spread of the new coronavirus. It is known that 
agglomeration makes isolation difficult and it tends to 
contribute to the spread of diseases, especially 
respiratory ones and others involving direct contact. It 
can also be linked to psychological and stress 
conditions. 
The figure 1 below contains a sample of some of the 
indicators which were used to develop the vulnerability 
Index. Each one was attributed a grade from 0 to 100, 
the closer to 0, the lesser the susceptibility to the 
spread of diseases. Then, all results will be added and 
divided by the number of total indicators to obtain the 







                          ISSN: 1984-7688 
	
	 e-Scientia, Belo Horizonte, v. 14, n. 1  (2021).  




Figure 1: Example of Indicators used to develop the Vulnerability Index 
CATEGORY INDICATOR JUSTIFICATION SCORE 
SOCIOECONOMIC 
ASPECTS 
Income Higher-income makes it 
possible to enjoy better 
health status throughout the 
acquisition of health services, 
housing and living conditions. 
No income or government aid: 100 
< 0.5 minimum wage per capita: 80 
0.5 to 0.1 minimum wage per capita: 60 
1 to 2 minimum wage per capita: 40 
2 to 3 minimum wage per capita: 20 
> 3 minimum wage per capita: 0 
HOUSING Cohabitation Overcrowded living spaces, 
with more than one family 
living at the same house, 
tend to favor the spread of 
infectious diseases. 
Density of residents per bedroom:  
Less than 3: 0 





Existence of safe spaces to 
gather can influence the 
maintenance of physical and 
mental health. 
Public spaces located within a radius up 
to 1 km from the slum: 0 
greater than 1 km from the slum: 100 
INFRASTRUCTURE Public water 
supply system 
Access to safe water 
supplies allows several uses, 
such as human consumption, 
bathing, washing food, 
watering crops, and therefore 
it directly interferes in the 
spread of parasites and other 
pathologies transmitted by 
water. 
Public network: 0 
Clandestine connection: 50 
No water supply: 100 
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For the conclusion of the study, the index will be 
applied in local slums in Curitiba and Belo Horizonte, 
Brazilian state capitals where the study members 
reside, in order to test the indicators and undergo 
comparative studies.  
Since adequate housing is a human right in the The 
Universal Declaration of Human Rights (United 
Nations), the local governments must be able to 
provide assistance and living improvements to people 
in situations that are more vulnerable. This study is an 
important method to help to comprehend how physical, 
social and economic factors favor the spread of 
diseases in slums. It can be an important tool for the 
authorities to define priorities actions in each in 
attending to the precariousness of informal urban 
settlements, helping to improve public health and 
ensuring fundamental rights. Furthermore, it can be a 
tool for people who live in precarious conditions to 





ALMEIDA, M. A. P. D. Indicadores de Salubridade 
Ambiental em Favelas Urbanizadas: o Caso de 
Favelas em Áreas de Proteção Ambiental. Tese 
(Doutorado em Engenharia Civil) - Universidade de 
São Paulo, São Paulo, 1999.  
CityMetric, 2020. Slums are becoming a focal point of 
the Covid-19 outbreak. Available at: 
<https://igarape.org.br/slums-are-becoming-a-focal-
point-of-the-covid-19-outbreak/>. Accessed 20 August 
2020.  
CORBURN, J. et al. Slum Health: Arresting COVID-19 
and Improving Well-Being in Urban Informal 
Settlements. J Urban Health. 2020;97(3):348-357. 
Available at: 
<https://pubmed.ncbi.nlm.nih.gov/32333243/>. 
Accessed 20 August 2020.  
Division, UN., 2019. — SDG Indicators. [online] 
UNstats. Available at: 
<https://unstats.un.org/sdgs/report/2019/goal-11/>. 
Accessed 20 August 2020. 
LAKATOS, E. M. MARCONI, Marina de Andrade. 
Fundamentos de metodologia científica 1. 5ª ed. São 
Paulo: Atlas, 2003. 
LIMA, K. W. S. de; ANTUNES, J. L. F.; SILVA, Z. P. 
da. Percepção dos gestores sobre o uso de 
indicadores nos serviços de saúde. Saúde soc., São 
Paulo, v. 24, n. 1, p. 61-71, Mar.  2015. Available at: 
<http://www.scielo.br/scielo.php?script=sci_arttext&pid
=S0104-12902015000100061&lng=en&nrm=iso>. 
Accessed 20 August  2020.   
OMS, 2002. ONU - Organização das Nações Unidas. 
Declaração Universal dos Direitos Humanos da ONU. 
 
                          ISSN: 1984-7688 
	
	 e-Scientia, Belo Horizonte, v. 14, n. 1  (2021).  




ANAIS DO I GLOBAL HEALTH INTERNATIONAL CONGRESS 
EXPANDED SUMMARY 
 
IN TIMES OF CRISIS, DOES THE URGENCY OF TREATING AN 
EMERGING DISEASE OUTWEIGH EVIDENCE-BASED MEDICINE? 
 
EM TEMPOS DE CRISE, A URGÊNCIA DE TRATAR UMA EMERGENTE DOENÇA 
SUPERA A MEDICINA BASEADA EM EVIDÊNCIA? 
 
Maria Eduarda Coelho Da Maia1*; Carolina Turra Fadanelli²; Eduarda Miot 








ABSTRACT: On January 30, 2020, the World Health Organization (WHO) declared the new 
coronavirus an International Public Health Emergency. Thus, medicine found itself at war against a 
still very unknown enemy, in which Evidence-Based Medicine (EBM) can be a tool when it comes to 
methodology and strategy for combat. The objective of this study was to analyze the possible actions 
in a time of health emergency, bringing Evidence-Based Medicine in its various forms as the main 
point of the search for standardized and effective medical conduct. Concerning the methodology, it is 
a narrative review of literature, of a qualitative nature and the bibliographic search was carried out in 
July 2020 in the Scielo and Pubmed databases. It is pointed out that the number of studies related to 
Covid-19 is growing exponentially, however, the health professional must always evaluate and 
prioritize those that offer solid and impartial scientific evidence. In conclusion, it is essential that health 
professionals make their decisions safely, based on reliable interventions. This guarantee is only 
possible when there are strict studies on which to base it. 
 
Keywords: “Coronavirus Infections”, “Evidence-Based Medicine” and ‘’ Review’’. 
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On January 30, 2020, the World Health Organization 
(WHO) declared the new coronavirus an International 
Public Health Emergency, warning of the risks that 
exist in countries with vulnerable health systems. 
Thus, medicine found itself at war against a still very 
unknown enemy, in which the weapons to be used in 
combat are of unproven effectiveness. Therefore, 
Evidence-Based Medicine (EBM) is one of the most 
accurate tools when it comes to methodology and 
strategy for combat. However, its use has been 
questioned and neglected, in view of the urgency to 
find treatment responses and possible cures for Covid-
19. Thus, questions about the current validity of the 
MBE are constantly raised. An analysis of the 
approach taken against other agents with potential 
epidemiological risk, such as Ebola, and the precepts 
established by Medical Ethics can be the tools used to 
arrive at a medical approach standardization. The 
objective of this study was to analyze the possible 
actions in a time of health emergency, bringing 
Evidence-Based Medicine in its various forms as the 





It is a narrative review of literature, of a qualitative 
nature. A critical and personal analysis of the authors 
was carried out in an attempt to answer the question: 
“In times of crisis, does the urgency of treating an 
emerging disease surpass evidence-based 
medicine?’’. 
The bibliographic search was carried out in July 2020 
in the Scielo and Pubmed databases. There was no 
time limit, country of origin of the study and area of 
knowledge. Literature review and opinion article in 
English and Portuguese on the topic of interest was 
included in the research. Thus, 20 publications made 




5. RESULTS AND DISCUSSION 
 
Evidence-Based Medicine can be understood as being 
explicit awareness and judicious use of the best 
current evidence in decision-making about the care of 
individual patients (SACKETT, et al., 1996). In this 
context, at the beginning of the 21st century, it was 
decided that medical decision-making should be based 
on three primary factors: the best available scientific 
evidence, the physician's experience and intuition, and 
the patient's preferences and values (SACKETT, et al., 
1996;  SACKETT, et al., 2000). 
It is known that the number of studies related to Covid-
19 is growing exponentially on a daily basis, however, 
the health professional must always evaluate and 
prioritize those that offer solid and impartial scientific 
evidence. Despite recent data showing that about 95% 
of intensive care studies show no benefit (HARHAY, 
WAGNER, RATCLIFFE, et al., 2014), the hope of 
providing new treatments for Covid-19 exceeds the 
discouraging numbers. Therefore, the health 
professional, when analyzing a scientific article, must 
know the hierarchy of quality of evidence to be used as 
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a tool in the conduct with his patient. In order of most 
relevant to least relevant there are: systematic 
reviews, randomized controlled clinical studies, cohort 
studies, case control studies, case series and case 
reports (SACKETT, et al., 2000). Finally, expert 
opinion is rarely used, only in cases where there is no 
stronger evidence (SACKETT, et al., 2000). 
It is worth mentioning that, although the hierarchy of 
levels of evidence is dynamics since new studies 
appear every day and new hypotheses are formulated, 
MBE still aims to comply with less risky clinical 
decisions and with rates of minimized errors and 
unwanted effects. In this sense, the Grading of 
Recommendations, Assessment, Development and 
Evaluations (GRADE) is the platform most used by 
health professionals, gathering important evidence and 
recommendations for clinical practice, in order to guide 
on the quality of published studies. In it, there are four 
levels of evidence, also known as certainty of evidence 
or quality of evidence: very low, low, moderate and 
high, with evidence from randomized clinical trials 
generally classified as high quality (GUYATT, OXMAN, 
VIST, et al., 2008). In this way, the recognition of the 
quality of the evidence will help to avoid errors, as 
insufficient attention to the quality of the study allows 
the formulation of inappropriate guidelines and 
recommendations that can influence doctors to act to 
the detriment of their patients (SIEMIENIUK, 
GUYATT). 
Non-specialists on the subject of Evidence-Based 
Medicine may think that only medical professionals 
use evidence to guide their conduct. However, the 
MBE panorama has expanded to include subjects 
such as Nursing, Dentistry, Public Health and Health 
Policies. Thus, the importance of the subject goes 
beyond medicine, encompassing the evidence-based 
conduct of the entire multidisciplinary team that aims to 
help the patient in a vulnerable situation (FERGUSON, 
et al., 2005). 
Currently, the scientific need for evidence-based 
implementation is recognized to ensure the optimal 
functioning of clinics, hospitals and health services 
(DJULBEGOVIC, 2014) and to make public health 
policy decisions. One difficulty with public health 
systems in several countries is the resources 
allocation to ensure that the program works correctly. 
Thus, health research will produce alternatives for the 
detection, prevention and treatment of diseases, but 
budget restrictions will not allow access to the entire 
population (CANUTO, 2012). For that, the cost-
effectiveness analysis is used, which is a form of 
complete economic evaluation in which both the costs 
and the consequences of health treatments are 
examined (CANUTO, 2012). This analysis makes it 
possible to save more lives in the context of a 
pandemic, assuming the recurrent scarcity of 
resources in the world's public health systems. 
In the uncertain context of a tragic Ebola epidemic or a 
pandemic as in Covid-19, it is evident how necessary 
responses are needed. Like the avian flu, the World 
Health Organization offered guidelines that were 
supported by a rapid review methodology, in which 
only 12 weeks passed from the formation of the 
guidelines panel to the conclusion of the 
recommendations (SCHÜNEMANN, HILL, KAKAD, et 
al., 2007). This experience shows that the rapid 
synthesis of evidence can be done to support 
decisions that range from clinical policies to health 
policies (SCHÜNEMANN, MOJA, 2015). 
The delay in most revolutionary randomized clinical 
trials should not persuade the physician to believe that 
doing something is better than doing nothing. This is 
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because, according to the principle of beneficence and 
not maleficence, the physician's action must always 
cause the least damage or aggravation to the patient's 
health, reducing the adverse or undesirable effects of 
diagnostic and therapeutic actions in humans and 
maximizing the benefits to their integrity and quality of 
life (BEAUCHAMP, CHILDRESS, 1989). 
In addition, it is always important to provide the patient 
with proper information about their health condition, 
risks, and appropriate measures so that the shared 
decision of conduct is possible; even in cases of 
scarce evidence and when individuals are unable to 
make choices concrete personal information without 
supporting the numerical probabilities to which they 
are subject (FERGUSON, et al, 2005). Thus, the 
development of person-centered care emphasized the 
priority of considering an individual perspective, with 
the patient's role not only consenting to what is offered 
by the health system, but being an active part in 
choosing and adapting treatment according to their 
needs, resulting, ideally, in a joint decision on 
treatment (SANDMAN, MUNTHE, 2010), which 
advocates one of the three basic pillars of EBM. 
When it comes to diseases in advanced stages and 
with little probability or hope of cure, patients tend to 
make decisions about therapy that can hopefully bring 
about a longer survival or regression of the disease, 
even if this treatment has little evidence (SANDMAN, 
LILIEMARK, 2017). The health professional must show 
and explain to the patient the scientific information 
about the medications and treatments available and try 
to avoid producing more harm to the individual. This 
fact can be applied not only to conducts for more lethal 
diseases, but also to test treatments for relatively new 
diseases, such as Covid-19. Corroborating this 
perspective, studies show that patients and 
professionals alike have difficulty understanding and 
interpreting information about probabilities and risks 
(PILARSKI, 2009; REYNA, 2009), showing that, more 
than the unbridled production of new scientific articles, 
it is essential to train professionals to work with the 
information presented. 
It is known, however, that scientific articles produced in 
a short period can have important flaws, such as the 
suppression of research results (DJULBEGOVIC, 
GUYATT, 2017). However, if the validity of the review 
is not compromised, they can and should be done 
quickly, respecting the conduct guidelines and being 
transparent regarding the results (SCHÜNEMANN, 
MOJA, 2015). Thus, quick reviews that are not 
systematic run the risk of any other narrative review, 
making it necessary to always produce quality and 
genuine articles, even during a period of crisis. 
Although the evaluation of drug efficacy involves in 
vitro studies as an initial step, new treatments should 
be adopted after more prolonged and rigorous stages 
of studies in humans, thro’ugh randomized clinical 
trials to really understand their benefits and risks 
(BHIMRAJ, et al., 2020). Only from then on, these 
substances could become evidence-based therapeutic 
resources, since in similar cases, several drugs have 
failed RCT tests. In this way, the “abandonment” of the 
principles of Evidence-Based Medicine can occur due 
to fear, overload professionals, due to lack of time to 
produce quality RCT studies or credibility of some 
professionals, who mistakenly believe that after some 
months of experience a complex syndrome is already 
known, which violates the ethical principle of non-
maleficence to the patient. 
Thus, EBM and the use of evidence are an essential 
requirement in the introduction of new treatments in 
the health area, as well as in the reevaluation of old 
treatments (SANDMAN, LILIEMARK, 2017). The 
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beneficial effects of this development include: more 
safety by health professionals when providing 
information to the patient about the promised effects of 
treatment, less chance of unexpected and serious side 
effects, and the use of limited resources in treatments 
that really work for a reasonable cost. 
MBE needs to also include mathematical, sociological 
and anthropological analyzes of local changes caused 
by a disease, like Ebola again, since it is already 
possible to measure the actions taken and their 
effects. Mathematical models produce evidence to 
support political decisions in new outbreaks and viral 
pandemics and in situations of uncertainty. 
Sociological and anthropological work shows how 
pandemic models do not always adapt well in their 
local contexts of implementation and can perpetuate 
the damage by silencing rationalities and alternative 
models (RHODES, et al., 2020). It is clear, therefore, 
the need to check the patterns of disease beyond the 
niche in the health area. 
Continued updating has always been an important 
requirement for good medical practice. Nowadays, 
globalization, at the same time that it allows a fast 
traffic of information, can have harmful effects, 
depending on how this information will be treated, a 
term currently known as ´infodemic´ (GARCIA, et al., 
2020). In this sense, Evidence-Based Medicine is a 
tool that should contribute to the training of 
professionals capable of properly selecting the source 
of knowledge and transferring information to medical 
practice, through attitudes that result in improving the 
quality of care. It is essential that health professionals 
make their decisions safely and that their interventions 
are reliable, making it unlikely that any undesirable 
effect will occur for the patient (EL DIB, 2007). This 
guarantee is only possible when there are strict studies 
on which to base it. Finally, adaptive science is present 
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